More details are available for ECCP Members. To become a member click here.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca is among the Top 10 largest multinational pharmaceutical companies in the Philippines. It is home to 220 employees nationwide who understand that their mission is not just to make high quality medicines available, but to offer physicians the opportunity to constantly enhance patient care. We invest over US$5.6 billion every year in research and development of new medicines to meet patient needs. AstraZeneca Philippines takes part in global research with 13 dedicated people working on 11 ongoing clinical trials, involving more than 958 patients, in more than 40 sites all over the Philippines.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca is among the Top 10 largest multinational pharmaceutical companies in the Philippines. It is home to 220 employees nationwide who understand that their mission is not just to make high quality medicines available, but to offer physicians the opportunity to constantly enhance patient care. We invest over US$5.6 billion every year in research and development of new medicines to meet patient needs. AstraZeneca Philippines takes part in global research with 13 dedicated people working on 11 ongoing clinical trials, involving more than 958 patients, in more than 40 sites all over the Philippines.
Serving the European-Philippine business community since 1978, the ECCP remains committed to enabling cross-sector collaboration, promoting economic growth, and championing a sustainable future. For inquiries or further information, you may contact us directly or connect with us through our official social media channels.